loader
  • Lymphoma Research Experts
  • Logo LYSA
  • Logo LYSARC
  • Menu
  • Member
    area
  • S'informer sur le lymphome
  • Comprendre la recherche sur le lymphome
  • L'écosystème Experts Recherche Lymphome
  • Logo LYSA
    Lysa
  • Logo LYSARC
    Lysarc
  • CALYM
  • News
  • Contact
  • Espace presse
  • On parle de nous
  • Liens utiles
|
Logo LYSA Lysa
  • Presentation of the LYSA research network
  • Browse the current clinical studies
  • Consult our publications and presentations at congresses
  • Participate in a LYSA clinical study
  • Make a donation to contribute to research
  • Subscribe to the LYSA
Logo LYSARC Lysarc
  • Discover the operational structure LYSARC
  • Information about multidisciplinary expertise
  • Access the research offer
  • Browse the research platforms
  • Collaborating with the LYSARC
  • Join the LYSARC teams
CALYM
  • Presentation of the Carnot CALYM Institute
  • Learn more about the member entities
  • Explore the resources of the consortium
  • Access the R&D offer
  • Collaborate with the CALYM Carnot Institute
  • Join the Calym teams
  • The Carnot Institutes network
  • RedTalks a serie of scientific webinars
Home > LYSA’s RELEVANCE Trial in the Media
Lysa 19 June 2018

LYSA’s RELEVANCE Trial in the Media

Return on the presentation of Franck Morschhauser, from Claude Huriez Hospital (Lille, France), president of the LYSA scientific committee, on the interim results obtained for the phase III clinical trial RELEVANCE.

Please, discover the press release on this study, published on the website of ASHand the video made by ecancer!

Reference: Franck Morschhauser et al. Relevance : Phase III Efficacity and safety study of lenalidomide plus rituximab (R2) versus  rituximab plus chemotherapy, followed by rituximab, in previously untreated follicular lymphoma.

News

23 May 2022 Lysa
LYSA studies presented during 2022 ASCO and E...
2 oral communications an 4 posters presented by LYSA in the program of thes...
16 May 2022 Lysa
Health’s Broadcast Magazine de la santé &#...
The reference health broadcast called Le Magazine de la santé on France 5,...
21 November 2021 Lysa
LYSARC – Review of the 2020 Assessment ...
LYSARC - 2020 Review and outlook for 2021
Voir toutes les actualités
Experts Recherche Lymphome
  • Qu'est ce qu'un lymphome ?
  • S’informer sur le lymphome
  • Comprendre la recherche sur le lymphome
  • L'écosystème Experts Recherche Lymphome
Lysa
  • Presentation of the LYSA research network
  • Browse the current clinical studies
  • Consult our publications and presentations at congresses
  • Participate in a LYSA clinical study
  • Make a donation to contribute to research
  • Subscribe to the LYSA
in_icon tw_icon
Lysarc
  • Discover the operational structure LYSARC
  • Information about multidisciplinary expertise
  • Access the research offer
  • Browse the research platforms
  • Collaborating with the LYSARC
  • Join the LYSARC teams
in_icon
CALYM
  • Presentation of the Carnot CALYM Institute
  • Learn more about the member entities
  • Explore the resources of the consortium
  • Access the R&D offer
  • Collaborate with the CALYM Carnot Institute
  • Join the Calym teams
  • The Carnot Institutes network
  • RedTalks a serie of scientific webinars
in_icon tw_icon
Practical
  • Contact
  • Espace presse
  • On parle de nous
  • Liens utiles
  • Mentions légales et politique de confidentialité
  • Cookies
© Copyright LYSARC – 2022. All rights reserved.
Pamplemousse Communication #BEHAPPYBRAND – Agence communication & digitale